Cure My Disease

Don't miss your cure!

 Log in / Sign up

Why do some sepsis survivors struggle long after leaving the ICU?

NCT ID NCT07863128

Knowledge-focused Sponsor: University of Geneva, Switzerland Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Oct 07, 2026 · Last updated Oct 08, 2026 · Updated 1 time

Summary

Researchers are following adults who were admitted to intensive care with sepsis to understand what shapes their recovery over six months. The study collects medical data during the ICU stay and checks in by phone at 3 and 6 months to measure quality of life, thinking, mental health, and return to work. By looking at infection details, treatment timing, and hospital practices, the team aims to find factors that might be changed to help future sepsis survivors.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If researchers identify factors linked to poor recovery, future studies could test ways to improve long-term quality of life for sepsis survivors.
What could go wrong
This observational study cannot prove cause and effect, and results may not apply to all hospitals or patients. Sepsis recovery varies widely, so findings could be limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 530 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2026

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients (18 years or older) consecutively admitted to participating ICUs with community- or hospital-acquired sepsis diagnosed by the treating clinician at ICU admission and, where locally available, meeting Sepsis-3 criteria. Participating ICUs are academic and non-academic centres in several countries. Participants represent a broad spectrum of disease severity, comorbidity and infection source. Sepsis acquired in the ICU and patients admitted for palliative care are not included. No experimental intervention is administered; all treatments follow local standard of care. Because sepsis is an emergency condition and patients frequently lack decision-making capacity at the time of ICU admission, patients are included immediately and consent is obtained from a legal representative or next of kin as soon as possible and from the patient post hoc once capacity is recovered, in accordance with articles 30 and 31 of the Swiss Human Research Act.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older * Sepsis (community- or hospital-acquired) diagnosed on ICU admission, defined as either: (a) a diagnosis of sepsis made by the treating clinician at ICU admission AND fulfilment of Sepsis-3 criteria; or (b) a diagnosis of sepsis made by the treating clinician at ICU admission alone, where Sepsis-3 criteria are not routinely available according to local protocol Exclusion Criteria: * Refusal to participate, by the patient or the legal representative * Inability to ensure follow-up (e.g. overseas residence, no fixed home address) * Sepsis acquired in the ICU * Patient admitted for palliative care

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Long term care are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Long term care Long term follow-up Long term outcomes PICS Sepsis Sepsis scores

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hopitaux Universitaires de Geneve (HUG)

    RECRUITING

    Geneva, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.